The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: The pivotal role of the clinical laboratory

Annals of Clinical Biochemistry

Volumn 48, Issue 4, 2011, Pages 295-299

  Sturgeon, Catharine M ^a   Duffy, Michael J ^b   Walker, Graeme ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ABDOMINAL DISTENSION; ABDOMINAL RADIOGRAPHY; ANOREXIA; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CHRONIC LIVER DISEASE; CLINICAL LABORATORY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOMETRIOSIS; ENDOMETRIUM CANCER; GENERAL PRACTITIONER; HUMAN; LIVER CANCER; LUNG CANCER; MEDICAL AUDIT; MENSTRUATION; OVARY CANCER; PANCREAS CANCER; PANCREATITIS; PELVIS PAIN SYNDROME; PELVIS RADIOGRAPHY; PERITONITIS; PLEURISY; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK OF MALIGNANCY INDEX; SATIETY; SCORING SYSTEM; UTERINE CERVIX CANCER; UTERUS CANCER;

ABDOMEN; CA-125 ANTIGEN; CLINICAL LABORATORY TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; GREAT BRITAIN; HUMANS; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; PELVIS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 79960469807     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2011.011117     Document Type: Article

References (21)

1. Hamilton W, Peters TJ, Bankhead C, et al. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ 2009;339:b2998
2. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91
3. NICE Clinical Guideline 122. The Recognition and Initial Management of Ovarian Cancer. 2011. See http://guidance.nice.org.uk/CG/Wave17/22 (last checked 24 June 2011)
4. Redman C, Duffy S, Bromham N, et al. Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ 2011;342:973-6
5. UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). See http://www.instituteforwomenshealth.ucl.ac.uk/academic_research/gynaecologicalcancer/gcrc/ukctocs (last checked 24 June 2011)
6. UK Familial Ovarian Cancer Screening Study (UK FOCSS). 2010. See http://www.instituteforwomenshealth.ucl.ac.uk/academic_research/gynaecologicalcancer/gcrc/ukfocss (last checked 24 June 2011)
7. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011;305:2295-303
8. Davies AP, Jacobs I, Woolas R, et al. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993;100:927-31
9. Royal College of Obstetricians and Gynaecologists. Guideline No. 34. Ovarian Cysts in Postmenopausal Women. 2003. See http://www.rcog.org.uk/womens-health/clinical-guidance/ovarian-cysts-postmenopausalwomen-green-top-34 (last checked 24 June 2011)
10. Department of Health. Key Messages for Ovarian Cancer for Health Professionals. 20 February 2009. See http://www.dh.gov.uk/en/Healthcare/Cancer/DH_095624 (last checked date 29 May 2011)
11. Kim MK, Kim K, Kim SM, et al. A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol 2009;20:238-42
12. Kim YT. A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol 2010;21:65
13. Sturgeon CM, Lai LC, Duffy MJ. Serum tumour markers: how to order and interpret them. BMJ 2009;339:852-8
14. Nordin AJ, Ledermann JA, Kehoe S. NICE Guidelines: CA125 in the detection of ovarian cancer. BMJ [serial on the Internet]. 2011. See http://www.bmj.com/content/342/bmj.d3022/reply (last checked 24 June 2011)
15. Crosswell JM, Kramer BS, Crawford ED. Screening for prostate cancer with PSA testing: Current status and future directions. Oncology 2011;25:1-14
16. Routes to diagnosis - NCIN data briefing. 2011. See http://www.ncin.org.uk/publications/data_briefings/routes_to_diagnosis.aspx (last checked 24 June 2011)
17. New guidelines for early detection of ovarian cancer. Lancet 2011;377:1544
18. Berg J, Lane V. Pathology Harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory. Ann Clin Biochem 2011;48:195-7
19. Moore RG, Jabre-Raughley M, Brown AK, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010;203:228e1-6
20. Montagnana M, Danese E, Ruzzenente O, et al. The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? Clin Chem Lab Med 2011;49:521-5
21. Wilson J, Junger G. Principles and Practice of Screening for Disease. Geneva: WHO, 1968